Panel: Building a sustainable commercial future for rare and nano-rare advanced therapies

CDMO CRO & Partnering,Clinical Development & Regulatory Strategy,Commercialisation & Market Access,Patient Access Equity & Advocacy

Academic & Clinical Researchers,Biotech,Clinicians,Patient Advocates & Organizations,Payers,Pharma,Regulators & Policy Makers,Service Providers (CDMOs CROs & Suppliers),Tools tech & equipment providers